Oxford BioMedica (GB:OXB) has released an update.
Oxford BioMedica PLC has notified stakeholders of a change in major holdings, revealing that investment giant BlackRock, Inc. has adjusted its voting rights and financial instrument holdings to fall below the 5% threshold. The notification, dated 18th July 2024 and announced the following day, reflects BlackRock’s decreased position from a previous total of just over 5%. This shift could be of interest to investors tracking significant shareholder movements and the potential impact on Oxford BioMedica’s stock.
For further insights into GB:OXB stock, check out TipRanks’ Stock Analysis page.
